SCHEMBL17280243

SCHEMBL17280243

c1ccc(-c2c[nH]c(-c3ccc4ccc(-c5nc(-c6ccccc6)c[nH]5)cc4c3)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.49
CYP1B1 Q16678 1/20 0.49
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
CYP1A2 P05177 3/20 0.40
CA12 O43570 1/20 0.40
PDGFRB P09619 2/20 0.38
CTRC Q99895 1/20 0.38
ALDH1A1 P00352 5/20 0.38
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
HPGD P15428 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
RAB9A P51151 2/20 0.38
NPC1 O15118 2/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 2/20 0.38
AXL P30530 1/20 0.38
CDK8 P49336 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31305440 0.95 CYP1A1 (0.56) CYP1A1CYP1B1CYP1A2CA12PDGFRB
SCHEMBL5128314 0.95 CYP1A1 (0.56) CYP1A1CYP1B1CYP1A2CA12PDGFRB
SCHEMBL27824986 0.93 CYP1A1 (0.50) CYP1A1CYP1B1ESR1ESR2CYP1A2
SCHEMBL4855853 0.89 CYP1A1 (0.49) CYP1A1CYP1B1ESR1ESR2CYP1A2
SCHEMBL2950013 0.89 CYP1A1 (0.53) CYP1A1CYP1B1CYP1A2CA12PDGFRB
SCHEMBL31305475 0.89 CYP1A1 (0.53) CYP1A1CYP1B1CYP1A2CA12PDGFRB
SCHEMBL17280181 0.87 MEN1 (0.43) CYP1A1CYP1B1PDGFRBALDH1A1MEN1
SCHEMBL17279786 0.87 MEN1 (0.46) PDGFRBALDH1A1MEN1KMT2AHPGD
SCHEMBL20382107 0.86 HPGDS (0.56)
SCHEMBL27843959 0.85 CYP1B1 (0.43) CYP1A1CYP1B1CYP1A2CA12PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020149206-A1 METHOD FOR PRODUCING ACRYLIC RESIN FILM コニカミノルタ株式会社 2020-07-23 WO disclosed
US-10012777-B2 Resin composition Konica Minolta, Inc. (JP) 2018-07-03 US disclosed
US-10012777-B2 Resin composition Konica Minolta, Inc. (JP) 2018-07-03 US disclosed
US-20150338563-A1 RESIN COMPOSITION, TRIAZOLE COMPOUND, OPTICAL FILM, POLARIZING PLATE, OPTICAL LENS, CIRCULARLY POLARIZING PLATE AND IMAGE DISPLAY DEVICE KONICA MINOLTA, INC (JP) 2015-11-26 US disclosed
US-20150338563-A1 RESIN COMPOSITION, TRIAZOLE COMPOUND, OPTICAL FILM, POLARIZING PLATE, OPTICAL LENS, CIRCULARLY POLARIZING PLATE AND IMAGE DISPLAY DEVICE KONICA MINOLTA, INC (JP) 2015-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150338563-A1 RESIN COMPOSITION, TRIAZOLE COMPOUND, OPTICAL FILM, POLARIZING PLATE, OPTICAL LENS, CIRCULARLY POLARIZING PLATE AND IMAGE DISPLAY DEVICE HRH3, HELZ, NBAS CYP1A1 1181/4885CYP1B1 1079/4885ESR1 2086/4885
US-10012777-B2 Resin composition NBAS, WDR5, HRH3 CYP1A1 1304/4885CYP1B1 1052/4885ESR1 1822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.